908 Devices Inc

908 Devices reported second quarter 2026 revenue of $16.1 million, a 23% increase year-over-year, driven by strong demand from U.S. state and local customers and the recent acquisition of NIRLAB. The company shipped 198 devices in the quarter, bringing its installed base to 4,101, and its adjusted EBITDA loss narrowed by more than 50% to $1.9 million. Management raised the low end of its full-year revenue guidance to a range of $68 million to $70 million, representing growth of 21% to 25%, and highlighted a $6 million ProtectIR order from an Asia Pacific corrections agency secured in July. The company also noted progress with its VipIR FTIR device, shipping more than 35 units in the quarter, and expects to exceed 100 VipIR shipments for the year.

908 Devices reported second-quarter revenue rose 23% to $16.1 million and raised its full-year 2026 revenue guidance to $68 million to $70 million. The company shipped 198 devices, expanding its installed base to 4,101, and saw gross margin improve to 52% while adjusted EBITDA loss narrowed by more than half to $1.9 million. It ended the quarter with $101.5 million in cash and marketable securities and no debt. A recently won $6 million ProtectIR order is expected to contribute in the second half, while potential upside from the U.S. military's AVCAD program remains excluded from guidance due to uncertain timing.

The global mobile mass spectrometers market is projected to grow from USD 1.68 billion in 2026 to USD 2.87 billion by 2031, at a compound annual growth rate of 11.3%. This growth is driven by increasing demand for real-time, on-site chemical analysis across sectors such as environmental monitoring, defense, and forensics. Ion sources held the largest component share in 2025 due to their critical role in sample ionization and the adoption of ambient ionization techniques. Field-deployable and backpack-based platforms led the product segment, valued for their portability and rapid deployment. North America is expected to maintain a dominant market position, supported by local manufacturing and strategic initiatives from key players including 1st Detect Corporation, 908 Devices, and Agilent Technologies.